25B-NBOH (2C-B-NBOH, NBOH-2C-B) is a derivative of the phenethylamine derived hallucinogen
2C-B
2C-B (4-Bromo-2,5-dimethoxyphenethylamine) is a psychedelic drug of the 2C family. It was first synthesized by Alexander Shulgin in 1974. In Shulgin's book '' PiHKAL'', the dosage range is listed as 12–24 mg. As a recreational drug, 2C-B is so ...
which has been sold as a
designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. D ...
. It acts as a potent
serotonin receptor agonist with similar affinity to the better-known compound
25B-NBOMe at
5-HT2A and
5-HT2C receptors with values of 8.3 and 9.4, respectively.
Legal status
Sweden
The
Riksdag added 25B-NBOH to
Narcotic Drugs Punishments Act under Swedish Schedule I (''"substances, plant materials and fungi which normally do not have medical use"'') as of January 26, 2016, published by
Medical Products Agency (MPA) in regulation ''HSLF-FS 2015:35'' listed as 25B-NBOH, and 2-(
-(4-bromo-2,5-dimetoxifenyl)etylaminoetyl)fenol.
United Kingdom
Analogues and derivatives
References
25-NB (psychedelics)
Designer drugs
Bromoarenes
{{hallucinogen-stub